Speaker "Savan Devani" Details Back



Digitally Detecting Developing Diseases


BioTrillion is a 1-year old health technology startup, headquartered in San Francisco, developing a mobile App powered by an AI-platform called BioEngine4DTM to digitally detect developing diseases.  BioEngine4D is designed to utilize retrospectively-aggregated Medical data and prospectively-generated LIFEdataTM, analyze this “big data of life” through computational advancements in machine learning and artificial intelligence, and apply it back to life and longevity via early disease detection.  The Company is currently focused on detecting key Neurologic and Dermatologic diseases and its mission is inherent in its slogan: “Data from Life.  Data for Life.”TM

BioTrillion aims to empower people with access to better healthcare — before becoming patients — by shifting disease detection earlier in the healthcare continuum.  Advances in technology have augmented our individual abilities in many ways, and better caring for our own health should be no exception.  After all, no one can care more for your health than yourself.  


Savan Devani is the Founder and CEO of BioTrillion.
Previously, Savan spent the majority of his 15-year career in the Life Sciences industry working with hundreds of public and private corporations as a healthcare investment banker with Citigroup and Deutsche Bank. From Analyst through Managing Director, Savan led 40 financing and M&A deals, totaling $35 billion in deal value, and learned many invaluable lessons working with clients across the drug, diagnostic, and device spectrum, such as Amgen, Eli Lilly, Fosun, Masimo, Medtronic, Pacific Biosciences, Shanghai Pharma, and many others. He began his career as a little bioengineer in a big lab at Life Technologies.
Savan graduated with a M.S.E. in Bioengineering from the University of Pennsylvania and a B.S.E. in Bioengineering focused in Computer Science from the University of California at Berkeley.
After many years of academic and professional experience in the healthcare field, a deeply personal experience later in life made Savan truly realize how much in healthcare needed to change – his mother was abruptly diagnosed with stage 4b cancer. This compelled Savan to ask “where were all the signs” and “isn’t there a better way,” which led him back to his Bioengineering roots by founding BioTrillion.